We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA: Routine Inspections to Focus On Pharmacovigilance Compliance
EMA: Routine Inspections to Focus On Pharmacovigilance Compliance
The EU’s drugs authority is advising manufacturers that routine inspections will now include a focus on compliance with pharmacovigilance reporting requirements.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor